Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Finch Therapeutics Group, Inc. (FNCH)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
   10-K10-K10-KS-1/A
Revenues  0.918.57.710.2
            Revenue growth  -95.4%140.1%-24.0% 
Cost of goods sold  0.00.00.023.9
Gross profit  0.918.57.7-13.7
            Gross margin  100.0%100.0%100.0%-135.0%
Selling, general and administrative   [+]116.578.547.27.4
Other operating expenses  -20.0-3.6-0.2 
EBITDA   [+]-90.1-54.0-38.5-20.7
            EBITDA margin  -10468.6%-291.6%-498.2%-203.5%
Depreciation and amortization  5.52.30.80.5
EBIT   [+]-95.6-56.3-39.2-21.1
            EBIT margin  -11108.2%-304.0%-508.4%-208.2%
Non-recurring items   [+]18.1   
Interest income  0.30.00.10.5
Other income (expense), net  -1.2-1.8-0.2-0.1
Pre-tax income  -114.6-58.2-39.3-20.8
Income taxes  0.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%
Net income  -114.6-58.2-39.3-20.8
            Net margin  -13315.4%-313.8%-509.7%-204.4%
   
Basic EPS   [+]($2.40)($1.48)($4.83)$0.00
Diluted EPS   [+]($2.40)($1.48)($4.83)$0.00
   
Shares outstanding (basic)   [+]47.739.28.17,295.8
Shares outstanding (diluted)   [+]47.739.28.17,295.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy